Cargando…

Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials

COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu, Tara M., Wald, Anna, Restar, Arjee J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303319/
https://www.ncbi.nlm.nih.gov/pubmed/37391114
http://dx.doi.org/10.1016/j.annepidem.2023.06.024
_version_ 1785065250021703680
author Babu, Tara M.
Wald, Anna
Restar, Arjee J.
author_facet Babu, Tara M.
Wald, Anna
Restar, Arjee J.
author_sort Babu, Tara M.
collection PubMed
description COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COVID-19 immunizations is presented in this manuscript.
format Online
Article
Text
id pubmed-10303319
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-103033192023-06-29 Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials Babu, Tara M. Wald, Anna Restar, Arjee J. Ann Epidemiol Commentary COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned associated complications of both COVID-19 infection and COVID-19 immunizations is presented in this manuscript. Elsevier Inc. 2023-06-28 /pmc/articles/PMC10303319/ /pubmed/37391114 http://dx.doi.org/10.1016/j.annepidem.2023.06.024 Text en © 2023 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Babu, Tara M.
Wald, Anna
Restar, Arjee J.
Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
title Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
title_full Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
title_fullStr Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
title_full_unstemmed Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
title_short Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
title_sort health equity necessitates the inclusion of gender identity data in covid-19 clinical trials
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303319/
https://www.ncbi.nlm.nih.gov/pubmed/37391114
http://dx.doi.org/10.1016/j.annepidem.2023.06.024
work_keys_str_mv AT babutaram healthequitynecessitatestheinclusionofgenderidentitydataincovid19clinicaltrials
AT waldanna healthequitynecessitatestheinclusionofgenderidentitydataincovid19clinicaltrials
AT restararjeej healthequitynecessitatestheinclusionofgenderidentitydataincovid19clinicaltrials